Entries of Fellermann, K. on the publication server

Herrlinger, K.R., Diculescu, M., Fellermann, K., Hartmann, H., Howaldt, S., Nikolov, R., Petrov, A., Reindl, W., Otte, J.M., Stoynov, S., Strauch, U., Sturm, A., Voiosu, R., Ammendola, A., Dietrich, B., Hentsch, B. and Stange, E.F. (2013) Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: The ENTRANCE study. Journal of Crohn's and Colitis 7 (8), pp. 636-643. Fulltext not available.

Herrlinger, K. R., Fellermann, K., Fischer, C., Kreisel, W., Deibert, P., Schoelmerich, J., Fleig, W. E., Ruhl, A., Reinshagen, M., Greinwald, R., Stange, E. F. and Schwab, M. (2004) Thioguanine‐nucleotides do not predict efficacy of tioguanine in Crohn's disease. Alimentary Pharmacology & Therapeutics 19 (12), pp. 1269-1276. Fulltext not available.

Herrlinger, K. R., Kreisel, W., Schwab, M., Schoelmerich, J., Fleig, W. E., Ruhl, A., Reinshagen, M., Deibert, P., Fellermann, K., Greinwald, R. and Stange, E. F. (2003) 6‐Thioguanine — efficacy and safety in chronic active Crohn's disease. Alimentary Pharmacology & Therapeutics 17 (4), pp. 503-508. Fulltext not available.